Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

Women with polycystic ovary syndrome are hyperandrogenemic and insulin resistant, which are associated with alterations in circulating lipid and lipoprotein levels. We sought to determine the prevalence of, and risk factors for, lipid abnormalities in these women. Non-Hispanic white women with polyc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of medicine 2001-12, Vol.111 (8), p.607-613
Hauptverfasser: Legro, Richard S, Kunselman, Allen R, Dunaif, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Adult
Androgens - blood
Biological and medical sciences
Blood Glucose - analysis
Body Mass Index
Cholesterol - blood
Disorders of blood lipids. Hyperlipoproteinemia
Female
Female genital diseases
Gynecology. Andrology. Obstetrics
Humans
Hyperlipidemias - blood
Hyperlipidemias - etiology
Insulin - blood
Lipids
Lipids - blood
Medical sciences
Metabolic diseases
Middle Aged
Obesity
Polycystic Ovary Syndrome - blood
Polycystic Ovary Syndrome - complications
Predictive Value of Tests
Regression Analysis
Reproductive system
Risk Factors
Triglycerides - blood
Tumors
Women
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Women with polycystic ovary syndrome are hyperandrogenemic and insulin resistant, which are associated with alterations in circulating lipid and lipoprotein levels. We sought to determine the prevalence of, and risk factors for, lipid abnormalities in these women. Non-Hispanic white women with polycystic ovary syndrome (n = 195) and ethnically matched control women (n = 62) had fasting blood obtained for hormone and lipid levels. Subjects were categorized by body mass index (nonobese
ISSN:0002-9343
1555-7162
DOI:10.1016/S0002-9343(01)00948-2